<html xmlns:v="urn:schemas-microsoft-com:vml" xmlns:o="urn:schemas-microsoft-com:office:office" xmlns="http://www.w3.org/TR/REC-html40">

<head>
<meta http-equiv="Content-Language" content="en-us">
<meta name="GENERATOR" content="Microsoft FrontPage 6.0">
<meta name="ProgId" content="FrontPage.Editor.Document">
<meta http-equiv="Content-Type" content="text/html; charset=windows-1252">



<title>Hi-R-Ed Online</title>
<style>
<!--
p
	{margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman";
	}
p.MsoNormal
	{mso-style-parent:"";
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Times New Roman";
	margin-left:0in; margin-right:0in; margin-top:0in}
table.MsoTableGrid
	{border:1.0pt solid windowtext;
	font-size:10.0pt;
	font-family:"Times New Roman";
	}
span.MsoCommentReference
	{}
-->
</style>
</head>

<body bgcolor="#FFFFFF">

<table border="1" cellspacing="0" cellpadding="2" width="950" style="border-collapse:collapse" bordercolor="#013554">
  <tr style="height: .75pt">
    <td width="17%" valign="top" style="width: 9%; padding: 3.0pt; background: #006B85; " bordercolor="#013554">
    <p>
    <a target="_blank" href="../Instructions.htm">
    <img border="0" src="../../Byram/CAUTI/images/Resources-LC.jpg" width="90" height="68"></a><font face="Copperplate Gothic Bold" size="1" color="#FFFFFF"><b> </b>
    <font color="#FFFFFF">
    Instructions</font></font></p>
    <p>
    <a href="mailto:comments@hi-r-ed.org?subject=I have a question re: Non-Adherent Diabetes Patient Course">
    <img border="0" src="../../Byram/CAUTI/images/Take_Another_Course-LC2.jpg" width="89" height="63"></a><font face="Copperplate Gothic Bold" size="1" color="#FFFFFF"><b>
    </b>
	<a href="mailto:comments@hi-r-ed.org?subject=I have a question re: Non-Adherent Diabetes Patient Course">
	<font color="#FFFFFF">Ask a question</font></a></font></p>
    <p><u><font size="6" color="#0000FF" face="Arial">
    <b>
    <a target="_blank" href="course_evel_pre.asp">
    <img border="0" src="../../Byram/CAUTI/images/Instructions-LC.jpg" width="90" height="68"></a><a href="../../Byram/IVAbx/cellulitis%20quiz.asp"> </a> </b></font></u>
    <font color="#FFFFFF" face="Copperplate Gothic Bold" size="1">Post-Test</font></p>
    <p>
    &nbsp;</td>
    <td width="89%" style="padding: 3.0pt" bgcolor="#006B85" valign="top">
    <table border="1" cellspacing="1" width="100%" cellpadding="4" bordercolor="#013554" id="table3" style="border-collapse: collapse">
      <tr>
        <td width="5%" bgcolor="#FFFFFF" valign="top">
<table border="0" width="100%" bgcolor="#DBCEAC" style="border-collapse: collapse">
	<tr>
		<td><b><font face="Arial" size="5">Medication Adherence Research</font></b></td>
	</tr>
</table>
<p style="margin-top: 0; margin-bottom: 0">&nbsp;</p>
<table border="0" width="100%" style="border-collapse: collapse">
	<tr>
		<td align="center">
		<div style="language:en-US;margin-top:7.68pt;margin-bottom:0pt;margin-left:
.38in;text-indent:-.38in;text-align:left;direction:ltr;unicode-bidi:embed;
mso-vertical-align-alt:auto;mso-line-break-override:none;punctuation-wrap:hanging">
			<span style="font-family: Arial">•</span><span style="font-family: Arial; color: black">Approximately 
			50% adherent</span></div>
		<div class="O1" style="language:en-US;margin-top:6.72pt;margin-bottom:0pt;
margin-left:.81in;text-indent:-.31in;text-align:left;direction:ltr;unicode-bidi:
embed;mso-vertical-align-alt:auto;mso-line-break-override:none;punctuation-wrap:
hanging">
			<span style="font-family: Arial">–</span><span style="font-family: Arial; color: black">Annual 
			cost for non-adherence $290 billion</span></div>
		<div class="O1" style="language:en-US;margin-top:6.72pt;margin-bottom:0pt;
margin-left:.81in;text-indent:-.31in;text-align:left;direction:ltr;unicode-bidi:
embed;mso-vertical-align-alt:auto;mso-line-break-override:none;punctuation-wrap:
hanging">
			<span style="font-family: Arial">–</span><span style="font-family: Arial; color: black">Annual 
			cost per patient doubles</span></div>
		<div style="language:en-US;margin-top:7.68pt;margin-bottom:0pt;margin-left:
.38in;text-indent:-.38in;text-align:left;direction:ltr;unicode-bidi:embed;
mso-vertical-align-alt:auto;mso-line-break-override:none;punctuation-wrap:hanging">
			<span style="font-family: Arial">•Increased adherence to diabetes 
			medications </span></div>
		<div class="O1" style="language:en-US;margin-top:6.72pt;margin-bottom:0pt;
margin-left:.81in;text-indent:-.31in;text-align:left;direction:ltr;unicode-bidi:
embed;mso-vertical-align-alt:auto;mso-line-break-override:none;punctuation-wrap:
hanging">
			<span style="font-family: Arial">–Reduces hospitalizations</span></div>
		<div class="O1" style="language:en-US;margin-top:6.72pt;margin-bottom:0pt;
margin-left:.81in;text-indent:-.31in;text-align:left;direction:ltr;unicode-bidi:
embed;mso-vertical-align-alt:auto;mso-line-break-override:none;punctuation-wrap:
hanging">
			<span style="font-family: Arial">–Reduces emergency room visits</span></div>
		<div class="O1" style="language:en-US;margin-top:6.72pt;margin-bottom:0pt;
margin-left:.81in;text-indent:-.31in;text-align:left;direction:ltr;unicode-bidi:
embed;mso-vertical-align-alt:auto;mso-line-break-override:none;punctuation-wrap:
hanging">
			<span style="font-family: Arial">–Offsets the increased cost of 
			drugs for adherence</span></div>
		</td>
		<td>
		<p align="center">&nbsp;</td>
	</tr>
</table>
<p style="text-align: left; direction: ltr; unicode-bidi: embed; punctuation-wrap: hanging; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</p>
<p style="text-align: left; direction: ltr; unicode-bidi: embed; punctuation-wrap: hanging; margin-top: 0pt; margin-bottom: 0pt">
<span style="font-size: 12.0pt; font-family: Arial; color: black">While there is 
a lot of misinformation and speculation about adherence and outcomes, good 
examples may be best seen in research regarding medication adherence. </span>
<span style="font-size: 12.0pt; font-family: Arial; color: black; font-weight: bold">
When medications are prescribed to assist in the control of blood sugar, there 
are a number of critical points where non-adherence can occur</span><span style="font-size: 12.0pt; font-family: Arial; color: black">, 
starting with filling and refilling prescriptions, and taking medications 
incorrectly. And at first glance, these adherence issues are not easily 
reflected in diabetes cost statistics. As you can imagine, a patient who doesn’t 
refill their prescriptions may have a lower cost of care for that particular 
part of their disease management but, as we will see, may have significantly 
higher costs for the consequences of their medication non-adherence. </span></p>
<p style="text-align: left; direction: ltr; unicode-bidi: embed; punctuation-wrap: hanging; margin-top: 0pt; margin-bottom: 0pt">
<span style="font-size: 12.0pt; font-family: Arial; color: black; font-weight: bold">
Research on medication adherence suggests that the adherence rate for patients 
with diabetes is around 50%.</span><span style="font-size: 12.0pt; font-family: Arial; color: black"><i><a href="(p14).htm">[7]</a></i> 
Adherence studies suggest that there may be both health and cost benefits to 
improving adherence. Annual health care costs for a non-adherent patient may 
average twice those of a patient who is adherent to their prescribed medication 
regimens. With a starting level of $290 billion for problems associated with 
non-adherence, there are a lot of savings to be had.</span></p>
<div class="O1" style="language:en-US;margin-top:0pt;margin-bottom:0pt;
margin-left:0in;text-indent:-.19in;text-align:left;direction:ltr;unicode-bidi:
embed;vertical-align:baseline;mso-line-break-override:none;punctuation-wrap:
hanging">
	<span style="font-size: 12.0pt; font-family: Arial; color: black">&nbsp;</span></div>
<p style="text-align: left; direction: ltr; unicode-bidi: embed; punctuation-wrap: hanging; margin-top: 0pt; margin-bottom: 0pt">
<span style="font-size: 12.0pt; font-family: Arial; color: black; font-weight: bold">
Improvement in adherence comes with both costs and benefits</span><span style="font-size: 12.0pt; font-family: Arial; color: black">.<i><a href="(p14).htm">[8]</a></i> 
In a study on adherence in patients on oral diabetes medications, which included 
nearly 57,000 individuals with type 2 diabetes, when adherence rates were raised 
from 50% to 100%, hospitalization rates dropped 23.3%, a significant reduction. 
Emergency room visits were also reduced, by 46.2%. This came at an increased 
cost for medications--from about $325 to $1105 per person, but resulted in an 
overall savings of $1.12-$1.14 for each dollar spent on these medications.
</span></p>
<p style="text-align: left; direction: ltr; unicode-bidi: embed; punctuation-wrap: hanging; margin-top: 0pt; margin-bottom: 0pt">
<span style="font-size: 12.0pt; font-family: Arial; color: black">Another recent 
study reported in October 2011 suggested that there were significant differences 
between more than 11,000 adherent and more than 400 non-adherent patients for 
severity of illness, income level, depression, and other potential factors.<i><a href="(p14).htm">[9]</a></i> 
Costs were increased in the non-adherent patients by $15,231 per year compared 
to $13,848 for the adherent patients. For the non-adherent patients, costs were 
specifically higher for inpatient and outpatient care. While pharmacy benefits 
were higher in adherent patients, this was offset by the significantly higher 
costs of inpatient and outpatient care. It should be noted that when the 291 
high-cost outlier patients were excluded from the evaluation, the costs were 
slightly higher for adherent patients, even though inpatient and outpatient care 
was less, due to the higher pharmacy benefit taken advantage of by adherent 
patients. In addition, this study suggested that the degree of adherence was 
related to hospitalization rates with more adherence which reflected fewer 
hospitalizations, when high-cost outliers were excluded.</span></p>
<p style="text-align: left; direction: ltr; unicode-bidi: embed; punctuation-wrap: hanging; margin-top: 0pt; margin-bottom: 0pt">
<span style="font-size: 12.0pt; font-family: Arial; color: black">When we 
revisit what can be done to improve adherence, we will see that efforts to 
reduce the complexity of medication regimens have shown some promise. In a 
meta-analysis of 17 studies, fixed dose combination therapies, for instance, 
showed significant improvements in adherence in addition to the associated lower 
direct medical costs (including medication costs), and improved patient 
satisfaction.<i><a href="(p14).htm">[10]</a></i></span></p>
<p style="text-align: left; direction: ltr; unicode-bidi: embed; vertical-align: baseline; punctuation-wrap: hanging; margin-top: 0pt; margin-bottom: 0pt">
&nbsp;</p>
<p style="text-align: left; direction: ltr; unicode-bidi: embed; punctuation-wrap: hanging; margin-top: 0pt; margin-bottom: 0pt">
<span style="font-family: Arial; color: black; font-style: italic">
<font style="font-size: 11pt">7. Reiter J. ADA 2011: Solving the challenge of medication adherence in patients 
with diabetes. June 27, 2011.&nbsp; Available at: http://www.hcplive.com/conferences/ada_2011/Solving-the-Challenge-of-Medication-Adherence-in-Patients-with-Diabetes.
</font>
</span></p>
<p style="text-align: left; direction: ltr; unicode-bidi: embed; punctuation-wrap: hanging; margin-top: 0pt; margin-bottom: 0pt">
<span style="font-family: Arial; color: black; font-style: italic">
<font style="font-size: 11pt">8. Encinosa WE, Bernard D, Dor A. Does prescription drug adherence reduce 
hospitalizations and costs? The case of diabetes. Adv Health Econ Health Serv 
Res. 2010;22:151-173.</font></span></p>
<p style="text-align: left; direction: ltr; unicode-bidi: embed; punctuation-wrap: hanging; margin-top: 0pt; margin-bottom: 0pt">
<span style="font-family: Arial; color: black; font-style: italic">
<font style="font-size: 11pt">9. Gleason PP, Starner CI, Zhou S, Ritter S. Journal of Managed Care Pharmacy. 
2011;17(3):244. Full presentation available at: http://www.amcp.org/WorkArea/DownloadAsset.aspx?id=13620.
</font>
</span></p>
<p style="text-align: left; direction: ltr; unicode-bidi: embed; punctuation-wrap: hanging; margin-top: 0pt; margin-bottom: 0pt">
<span style="font-family: Arial; color: black; font-style: italic">
<font style="font-size: 11pt">10. Hutchins V, Zhang B, Fleurence RL, Krishnarajah G, Graham J. A systematic 
review of adherence, treatment satisfaction and costs, in fixed-dose combination 
regimens in type 2 diabetes. Curr Med Res Opin. 2011;27(6):1157-1168. </font> </span>
</p>
<p style="text-align: left; direction: ltr; unicode-bidi: embed; vertical-align: baseline; punctuation-wrap: hanging; margin-top: 0pt; margin-bottom: 0pt">
&nbsp;</p>
		</td>
      </tr>
    </table>
    </td>
  </tr>
</table>

<p class="MsoBodyTextIndent"><b><font size="1" color="#015384">Click on the link 
at left to go to your desired page:&nbsp;</font></b></p>

<p class="MsoBodyTextIndent"><b><font color="#015384" size="1">
<a href="(intro).asp"><font color="#004B8D">Page 1</font></a></font><font size="1" color="#004B8D"><font size="1">&nbsp;</font>
</font>
<font size="1" color="#015384">
<a href="(p2).htm"><font color="#004B8D">Page 2</font></a><font size="1" color="#004B8D">&nbsp; </font>
</font>
<font size="1" color="#808080"><a href="(p3).htm">
<font color="#004B8D">Page 3</font></a></font><font size="1" color="#004B8D">&nbsp; </font><font size="1" color="#6699FF">
	<a href="(p4).htm"><font color="#004B8D">Page 4</font></a></font><font size="1" color="#004B8D">&nbsp; </font><font size="1" color="#6699FF"> 
	<a href="(p5).htm">
<font color="#004B8D">Page 5</font></a><font size="1" color="#004B8D">&nbsp; </font> 
<font color="#808080"><a href="(p6).htm">
<font color="#004B8D">Page 6</font></a></font><font size="1" color="#004B8D">&nbsp;
</font></font>
	<a href="(p7).htm">
	<font size="1" color="#004B8D">Page 7</font></a><font color="#004B8D" size="1">&nbsp;
	</font>
<font color="#015384" size="1">
	<a href="(p8).htm"><font color="#004B8D">Page 8</font></a></font><font color="#004B8D" size="1">&nbsp; </font>
<font size="1" color="#808080"><a href="(p9).htm">
<font color="#004B8D">Page 9</font></a></font><font size="1" color="#004B8D">&nbsp; 
</font><font size="1" color="#015384"><a href="(p10).htm"><font color="#004B8D">
Page 10</font></a></font><font size="1" color="#004B8D">&nbsp;</font><font size="1" color="#015384"><font size="1" color="#004B8D">&nbsp;<a href="(p11).htm">Page 
11</a>&nbsp; </font>
<a href="(p14).htm"><font color="#004B8D">References</font></a><font size="1" color="#004B8D">&nbsp; </font> 
<a target="_blank" href="course_evel_pre.asp">
<font color="#004B8D">Post-Test</font></a></font></b></p>

<table border="0" width="100%" id="table1">
	<tr>
		<td width="73"><i><a href="(p7).htm">
<font color="#015384">Continue</font></a></i></td>
		<td>
		<img border="0" src="../../Byram/Diab&Exer/images/arrow.gif" width="50" height="31"></td>
	</tr>
</table>

<h5 align="center"><font face="Arial" size="1">2018 Hi-R-Ed Online University. All courses posted on 
    this site are the property of Hi-R-Ed Online University unless otherwise 
    stated. Courses may not be copied or transferred in electronic, printed, or 
    other forms, or modified for any purpose without explicit written consent of Hi-R-Ed Online University.</font></h5>

<p align="center">&nbsp;</p>

</body>

</html>